XBiotech XBIT
NASDAQ XBIT
$2.18 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

XBiotech (XBIT) Price to Earnings (2015 - 2026)

XBiotech (XBIT) posted Price to Earnings of 10.42 for Q2 2026, down 284.65% on a QoQ basis from 2.71 in Q4 2025, and up 79.79% year-over-year from 5.8 in Q2 2025.

Analysis

XBiotech (XBIT) Price to Earnings (2015 - 2026) Analysis & Trends

XBiotech has reported Price to Earnings for 12 years, with the latest figure at 10.42 in Q2 2026.

  • On a quarterly basis, Price to Earnings rose 79.79% year-over-year to 10.42 in Q2 2026; TTM through Jun 2026 was 1.69, a 47.3% increase from a year earlier, with the FY2025 full-year figure at 1.6, up 48.81% from the prior year.
  • Price to Earnings was 10.42 for Q2 2026 at XBiotech, down from 2.71 in the prior quarter.
  • The five-year high for Price to Earnings was 2.71 in Q4 2025, with the low at 51.57 in Q2 2025.
  • Average Price to Earnings over 5 years is 22.27, with a median of 17.03 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Price to Earnings jumped 92.79% in 2022, then plunged 328.31% in 2025.
  • Over 5 years, Price to Earnings stood at 33.36 in 2022, then rose by 22.24% to 25.94 in 2023, then jumped by 55.81% to 11.46 in 2024, then surged by 76.36% to 2.71 in 2025, then slumped by 284.65% to 10.42 in 2026.
  • The last three Price to Earnings figures came in at 10.42 (Q2 2026), 2.71 (Q4 2025), and 13.5 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 XBiotech 66.16 Mn 66.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.42
Dec 31, 2025 -2.71
Sep 30, 2025 -13.50
Jun 30, 2025 -51.57
Mar 31, 2025 -9.08
Dec 31, 2024 -11.46
Sep 30, 2024 -46.98
Jun 30, 2024 -12.04
Mar 31, 2024 -24.75
Dec 31, 2023 -25.94
Sep 30, 2023 -17.03
Jun 30, 2023 -20.68
Mar 31, 2023 -27.00
Dec 31, 2022 -33.36
Sep 30, 2022 -8.71
Jun 30, 2022 -14.72
Mar 31, 2022 -48.75
Dec 31, 2021 -67.01
Sep 30, 2021 -120.72
Jun 30, 2021 -97.15